Cytokine expression and macrophage localization in xenograft and allograft tumor models stimulated with lipopolysaccharide

Junko Masuda, Tsukasa Shigehiro, Takuma Matsumoto, Ayano Satoh, Akifumi Mizutani, Chiho Umemura, Shoki Saito, Mayumi Kijihira, Eiji Takayama, Akimasa Seno, Hiroshi Murakami, Masaharu Seno

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

T cell-deficient mice such as nude mice are often used to generate tumor xenograft for the development of anticancer agents. However, the functionality of the other immune cells including macrophages, dendritic cells (DCs), and myeloid-derived suppressor cells (MDSCs) in the xenograft are largely unknown. Macrophages and dendritic cells (DCs) acquire functionally distinct properties in response to various environmental stimuli; the interaction of these cells with MDSCs in tumor microenvironments regulates cancer progression. Nude mice are less likely to reject human cancer cells because of major histocompatibility complex (MHC) mismatches. The tumor microenvironment in a xenograft, comprising human and mouse cells, exhibits more complex bidirectional signaling and function than that of allograft. Here, we evaluated the differences of myeloid cells between them. Plasma interferon-γ and interleukin-18 concentrations in the xenograft tumor model after lipopolysaccharide (LPS) administration were significantly higher than those in the allograft tumor model. MHC class I, II, and CD80 expression levels were increased in CD11b+ and MDSC populations after LPS administration in the spleen of a xenograft tumor model but not in that of an allograft tumor model. Additionally, the number of CD80-and mannose receptor C type 1 (MRC1)-expressing cells was decreased upon LPS administration in the tumor of the xenograft tumor. These results suggest that functions of macrophages and DCs are sustained in the xenograft, whereas their functions in response to LPS were suppressed in the allograft. The findings will encourage the consideration of the effects of myeloid cells in the xenograft for drug development.

Original languageEnglish
Article number1261
JournalInternational Journal of Molecular Sciences
Volume19
Issue number4
DOIs
Publication statusPublished - Apr 23 2018

Fingerprint

macrophages
Macrophages
Heterografts
Allografts
Lipopolysaccharides
Tumors
tumors
Cytokines
cells
Neoplasms
suppressors
mice
Dendritic Cells
Tumor Microenvironment
Myeloid Cells
Major Histocompatibility Complex
Nude Mice
Cells
Interferons
cancer

Keywords

  • Allograft tumor
  • Dendritic cells (DCs)
  • Lipopolysaccharide (LPS)
  • M1 macrophages
  • M2 macrophages
  • Myeloid-derived suppressor cells (MDSCs)
  • Xenograft tumor

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Cytokine expression and macrophage localization in xenograft and allograft tumor models stimulated with lipopolysaccharide. / Masuda, Junko; Shigehiro, Tsukasa; Matsumoto, Takuma; Satoh, Ayano; Mizutani, Akifumi; Umemura, Chiho; Saito, Shoki; Kijihira, Mayumi; Takayama, Eiji; Seno, Akimasa; Murakami, Hiroshi; Seno, Masaharu.

In: International Journal of Molecular Sciences, Vol. 19, No. 4, 1261, 23.04.2018.

Research output: Contribution to journalArticle

@article{ead8efd4049a43c0aa96984c297002be,
title = "Cytokine expression and macrophage localization in xenograft and allograft tumor models stimulated with lipopolysaccharide",
abstract = "T cell-deficient mice such as nude mice are often used to generate tumor xenograft for the development of anticancer agents. However, the functionality of the other immune cells including macrophages, dendritic cells (DCs), and myeloid-derived suppressor cells (MDSCs) in the xenograft are largely unknown. Macrophages and dendritic cells (DCs) acquire functionally distinct properties in response to various environmental stimuli; the interaction of these cells with MDSCs in tumor microenvironments regulates cancer progression. Nude mice are less likely to reject human cancer cells because of major histocompatibility complex (MHC) mismatches. The tumor microenvironment in a xenograft, comprising human and mouse cells, exhibits more complex bidirectional signaling and function than that of allograft. Here, we evaluated the differences of myeloid cells between them. Plasma interferon-γ and interleukin-18 concentrations in the xenograft tumor model after lipopolysaccharide (LPS) administration were significantly higher than those in the allograft tumor model. MHC class I, II, and CD80 expression levels were increased in CD11b+ and MDSC populations after LPS administration in the spleen of a xenograft tumor model but not in that of an allograft tumor model. Additionally, the number of CD80-and mannose receptor C type 1 (MRC1)-expressing cells was decreased upon LPS administration in the tumor of the xenograft tumor. These results suggest that functions of macrophages and DCs are sustained in the xenograft, whereas their functions in response to LPS were suppressed in the allograft. The findings will encourage the consideration of the effects of myeloid cells in the xenograft for drug development.",
keywords = "Allograft tumor, Dendritic cells (DCs), Lipopolysaccharide (LPS), M1 macrophages, M2 macrophages, Myeloid-derived suppressor cells (MDSCs), Xenograft tumor",
author = "Junko Masuda and Tsukasa Shigehiro and Takuma Matsumoto and Ayano Satoh and Akifumi Mizutani and Chiho Umemura and Shoki Saito and Mayumi Kijihira and Eiji Takayama and Akimasa Seno and Hiroshi Murakami and Masaharu Seno",
year = "2018",
month = "4",
day = "23",
doi = "10.3390/ijms19041261",
language = "English",
volume = "19",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

TY - JOUR

T1 - Cytokine expression and macrophage localization in xenograft and allograft tumor models stimulated with lipopolysaccharide

AU - Masuda, Junko

AU - Shigehiro, Tsukasa

AU - Matsumoto, Takuma

AU - Satoh, Ayano

AU - Mizutani, Akifumi

AU - Umemura, Chiho

AU - Saito, Shoki

AU - Kijihira, Mayumi

AU - Takayama, Eiji

AU - Seno, Akimasa

AU - Murakami, Hiroshi

AU - Seno, Masaharu

PY - 2018/4/23

Y1 - 2018/4/23

N2 - T cell-deficient mice such as nude mice are often used to generate tumor xenograft for the development of anticancer agents. However, the functionality of the other immune cells including macrophages, dendritic cells (DCs), and myeloid-derived suppressor cells (MDSCs) in the xenograft are largely unknown. Macrophages and dendritic cells (DCs) acquire functionally distinct properties in response to various environmental stimuli; the interaction of these cells with MDSCs in tumor microenvironments regulates cancer progression. Nude mice are less likely to reject human cancer cells because of major histocompatibility complex (MHC) mismatches. The tumor microenvironment in a xenograft, comprising human and mouse cells, exhibits more complex bidirectional signaling and function than that of allograft. Here, we evaluated the differences of myeloid cells between them. Plasma interferon-γ and interleukin-18 concentrations in the xenograft tumor model after lipopolysaccharide (LPS) administration were significantly higher than those in the allograft tumor model. MHC class I, II, and CD80 expression levels were increased in CD11b+ and MDSC populations after LPS administration in the spleen of a xenograft tumor model but not in that of an allograft tumor model. Additionally, the number of CD80-and mannose receptor C type 1 (MRC1)-expressing cells was decreased upon LPS administration in the tumor of the xenograft tumor. These results suggest that functions of macrophages and DCs are sustained in the xenograft, whereas their functions in response to LPS were suppressed in the allograft. The findings will encourage the consideration of the effects of myeloid cells in the xenograft for drug development.

AB - T cell-deficient mice such as nude mice are often used to generate tumor xenograft for the development of anticancer agents. However, the functionality of the other immune cells including macrophages, dendritic cells (DCs), and myeloid-derived suppressor cells (MDSCs) in the xenograft are largely unknown. Macrophages and dendritic cells (DCs) acquire functionally distinct properties in response to various environmental stimuli; the interaction of these cells with MDSCs in tumor microenvironments regulates cancer progression. Nude mice are less likely to reject human cancer cells because of major histocompatibility complex (MHC) mismatches. The tumor microenvironment in a xenograft, comprising human and mouse cells, exhibits more complex bidirectional signaling and function than that of allograft. Here, we evaluated the differences of myeloid cells between them. Plasma interferon-γ and interleukin-18 concentrations in the xenograft tumor model after lipopolysaccharide (LPS) administration were significantly higher than those in the allograft tumor model. MHC class I, II, and CD80 expression levels were increased in CD11b+ and MDSC populations after LPS administration in the spleen of a xenograft tumor model but not in that of an allograft tumor model. Additionally, the number of CD80-and mannose receptor C type 1 (MRC1)-expressing cells was decreased upon LPS administration in the tumor of the xenograft tumor. These results suggest that functions of macrophages and DCs are sustained in the xenograft, whereas their functions in response to LPS were suppressed in the allograft. The findings will encourage the consideration of the effects of myeloid cells in the xenograft for drug development.

KW - Allograft tumor

KW - Dendritic cells (DCs)

KW - Lipopolysaccharide (LPS)

KW - M1 macrophages

KW - M2 macrophages

KW - Myeloid-derived suppressor cells (MDSCs)

KW - Xenograft tumor

UR - http://www.scopus.com/inward/record.url?scp=85045904443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045904443&partnerID=8YFLogxK

U2 - 10.3390/ijms19041261

DO - 10.3390/ijms19041261

M3 - Article

C2 - 29690614

AN - SCOPUS:85045904443

VL - 19

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 4

M1 - 1261

ER -